Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Pharmacologic prophylaxis against nerve agent poisoning
Ido Layish
*
,
Amir Krivoy
, Eran Rotman
,
Arseny Finkelstein
, Zeev Tashma
, Yoav Yehezkelli
*
Corresponding author for this work
Israel Defense Forces
Research output
:
Contribution to journal
›
Review article
›
peer-review
44
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacologic prophylaxis against nerve agent poisoning'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acetylcholinesterase
33%
AChE Inhibitors
66%
Alzheimer's Disease
33%
Armed Forces
33%
Army
33%
Benzodiazepine Agonists
33%
Benzodiazepine Receptor
33%
Blood-brain Barrier
33%
Brain Injury
33%
Carbamate
33%
Civilian Use
33%
Convulsion
33%
Exposure Therapy
33%
Hypersecretion
33%
Military
33%
Nerve Agent Poisoning
100%
Nerve Agents
100%
NMDA Receptor Antagonist
33%
Partial Agonist
33%
Pharmacologic Prophylaxis
100%
Political Arena
33%
Prophylactic Treatment
100%
Pyridostigmine
100%
Rapid Progression
33%
Scavenger
33%
Transdermal Route
33%
Treatment Adjunct
33%
Tremor
33%
Western Countries
33%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylcholinesterase
50%
Alzheimer's Disease
16%
Benzodiazepine Receptor
16%
Benzodiazepine Receptor Stimulating Agent
16%
Blood-Brain Barrier
16%
Carbamic Acid Derivative
16%
Cholinergic Receptor Blocking Agent
16%
N Methyl Dextro Aspartic Acid Receptor Blocking Agent
16%
Nerve Gas
100%
Partial Agonist
16%
Pyridostigmine
50%
Toxic Injury
100%
Transdermal
16%
Medicine and Dentistry
Acetylcholinesterase
50%
Alzheimer's Disease
16%
Benzodiazepine Receptor
16%
Benzodiazepine Receptor Stimulating Agent
16%
Blood Brain Barrier
16%
Carbamic Acid Derivative
16%
Cleft
16%
Nerve Agent
100%
NMDA Receptor Antagonist
16%
Parasympatholytic
16%
Partial Agonist
16%
Pyridostigmine
50%
Transdermal
16%